# Seaport Therapeutics, Inc. Common Stock (SPTX)

> Seaport Therapeutics, Inc. Common Stock (SPTX) trades at $18.31 (+0.77%) as of 7:30:03 PM EST on Nov 18, 2026, -5.03% over the past month. Market cap is $980.14M, with 17.4 days to cover in short interest.

Canonical: https://massive.com/quote/sptx
Data as of: 2026-11-19T00:30:03.277Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## Price

**$18.31** +0.14 (+0.77%)
As of 7:30:03 PM EST on Nov 18, 2026 · 15-minute delayed
Nasdaq · usd

## Stock performance

How Seaport Therapeutics, Inc. Common Stock (SPTX) stock has performed from one day to one year, with its 52-week range.

| Period | Return |
| --- | --- |
| 1D | +0.77% |
| 1W | -14.08% |
| 1M | -5.03% |
| YTD | -7.71% |
| 1Y | -7.71% |
| 52-wk range | $14.85 – $28.38 |

From daily closes through Nov 18, 2026.

## Key statistics

Today's trading snapshot for SPTX: day range, open, previous close, volume and market cap.

| Measure | Value |
| --- | --- |
| Day range | $17.84 – $19.12 |
| Open | $18.19 |
| Prev close | $18.17 |
| Volume | 683.62K |
| Market cap | $980.14M |
| Shares out | 53.53M |

## Valuation and profitability ratios

Valuation and profitability ratios for Seaport Therapeutics, Inc. Common Stock: P/E, P/S, P/B, ROE and more.

| Measure | Value |
| --- | --- |
| P/E | — |
| P/S | — |
| P/B | 2.47 |
| P/FCF | — |
| ROE | -28.8% |
| ROA | -27.4% |
| Debt/Equity | 0.00 |
| Div yield | 0.00% |

As of Nov 18, 2026

## Insider trading

[Seaport Therapeutics, Inc. Common Stock (SPTX) insider trading](https://massive.com/quote/sptx/insider-trading.md): open-market Form 4 buys and sells by Seaport Therapeutics, Inc. Common Stock insiders over the last 12 months.

## 8-K filings

Material corporate events Seaport Therapeutics, Inc. Common Stock has disclosed to the SEC on Form 8-K.

- Nov 2, 2026 · [Quarterly earnings](https://massive.com/quote/sec-filings/8-k/earnings-releases.md)
  “On November 2, 2026, Seaport Therapeutics, Inc. (the "Company") announced its financial results for the quarter ended September 30, 2026.”
- May 4, 2026 · Bylaw amendment
  “The amended and restated bylaws of the Company (the "Amended and Restated Bylaws"), previously approved by the Board and the Company's stockholders to become effective immediately upon effectiveness of the Registration Statement, became effective. The Amended and Restated Bylaws amend and restate the Company's bylaws in their entirety to, among other things: (i) establish procedures for the Company's stockholders to take formal actions at meetings of stockholders; (ii) establish an advance notice procedure for stockholder proposals to be brought before an annual meeting of our stockholders, including proposed nominations of persons for election to our Board; (iii) establish procedures relating to the nomination of directors; and (iv) conform to the amended provisions of the Restated Certificate.”

## SPTX short interest

How heavily SPTX is shorted: shares short, days to cover and average daily volume.

| Measure | Value |
| --- | --- |
| Days to cover | 17.4 |
| Short interest | 3.73M |
| Avg volume | 214.34K |

As of Oct 30, 2026 · reported to FINRA twice monthly.

## SPTX news

The latest news and headlines about Seaport Therapeutics, Inc. Common Stock (SPTX).

- [How Much Upside is Left in Seaport Therapeutics, Inc (SPTX)? Wall Street Analysts Think 77.91%](https://www.zacks.com/stock/news/3024387/how-much-upside-is-left-in-seaport-therapeutics-inc-sptx-wall-street-analysts-think-77-91?cid=CS-ZC-FT-fundamental_analysis|consensus_price_target-3024387) · Zacks Investment Research · Nov 5, 2026 · positive sentiment

## About Seaport Therapeutics, Inc. Common Stock

Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified clinically validated mechanisms with established efficacy and safety profiles, historically limited by high first-pass metabolism, low bioavailability, and side effects. The company's pipeline products are based on Glyph, company's lymphatic-targeting prodrug technology is designed to bypass first-pass metabolism and thereby enhance a drug's oral bioavailability and reduce side effects.

| Measure | Value |
| --- | --- |
| Exchange | Nasdaq |
| Market | stocks |
| Type | CS |
| Currency | USD |
| Industry | PHARMACEUTICAL PREPARATIONS |
| IPO | $18.00 on May 1, 2026 |

[Seaport Therapeutics IPO page](https://massive.com/quote/sptx/ipo.md)

[Company website](https://www.seaporttx.com)

## FAQ

### What is the Seaport Therapeutics, Inc. Common Stock (SPTX) stock price today?

Seaport Therapeutics, Inc. Common Stock (SPTX) is trading at $18.31 (+0.77% on the day) as of 7:30:03 PM EST on Nov 18, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

### What is Seaport Therapeutics, Inc. Common Stock?

Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders.

### What is the short interest in SPTX?

As of Oct 30, 2026, SPTX has 3.73M shares short and 17.4 days to cover.

### What exchange is SPTX listed on?

Seaport Therapeutics, Inc. Common Stock (SPTX) trades on Nasdaq in USD, in the PHARMACEUTICAL PREPARATIONS industry.

## Live data

Prices here are 15-minute delayed. For real-time SPTX quotes and the full history behind this page, use the Massive API or MCP server:

- `GET https://api.massive.com/v3/snapshot?ticker.any_of=SPTX`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [Seaport Therapeutics, Inc. Common Stock (SPTX) insider trading](https://massive.com/quote/sptx/insider-trading.md)
- [SEC 8-K events](https://massive.com/quote/sec-filings/8-k.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms
